BRCA1 MUTATION CARRIER
Clinical trials for BRCA1 MUTATION CARRIER explained in plain language.
Never miss a new study
Get alerted when new BRCA1 MUTATION CARRIER trials appear
Sign up with your email to follow new studies for BRCA1 MUTATION CARRIER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail shows promise for Tough-to-Treat cancers
Disease control OngoingThis study tests two drug combinations (olaparib plus either vistusertib or capivasertib) in people with recurrent endometrial, triple-negative breast, ovarian, or related cancers. The goal is to find the safest dose and see if the drugs can control tumor growth. About 159 partic…
Matched conditions: BRCA1 MUTATION CARRIER
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 16, 2026 12:48 UTC
-
Could a diabetes drug stop breast cancer before it starts?
Prevention OngoingThis phase 3 trial tests whether metformin, a common diabetes drug, can prevent breast cancer in women at high risk. Eighty-six premenopausal women with atypical breast changes or genetic mutations took metformin or a placebo for 12 months. Researchers checked breast cell samples…
Matched conditions: BRCA1 MUTATION CARRIER
Phase: PHASE3 • Sponsor: Alliance for Clinical Trials in Oncology • Aim: Prevention
Last updated Jun 23, 2026 11:55 UTC